Drug-induced systemic Lupus erythematosus in interferon beta-1b therapy

Neuroendocrinology Letters

Volumn 32, Issue 1, 2011, Pages 4-6

  Sládkov́, Vladimíra ^a   Mareš, Jan ^a   Luběnová, Blanka ^a   Hluštík, Petr ^a   Kaňovský, Petr ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

Author keywords

Drug induced SLE syndrome; Interferon beta 1b therapy; Multiple sclerosis

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; CREATININE; GLATIRAMER; INTERFERON BETA SERINE; LA ANTIBODY; NATALIZUMAB; RO ANTIBODY;

ABSENCE OF SIDE EFFECTS; ADULT; ALBUMINURIA; ANTIBODY DETECTION; ANTIHYPERTENSIVE THERAPY; ARTICLE; CASE REPORT; CHEST OPPRESSION; CORTICOSTEROID THERAPY; DRUG WITHDRAWAL; DYSPNEA; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSURIA; HUMAN; HYPERTENSION; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY TUBULE ABSORPTION; MULTIPLE SCLEROSIS; NEUROLOGIC EXAMINATION; PROTEINURIA; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; THORAX DISEASE; XEROPHTHALMIA;

EID: 79955037334     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Beth L, Brogan MD, Nancy J, Olsen MD (2003). Drug-induced Rheumatic Syndromes. Curr Opin in Rheumatol. 15(1): 76-80.
2. Borchers AT, Keen CL, Gershwin ME (2007). Drug-induced lupus. Ann N Y Acad Sci. 1108: 166-82. (Pubitemid 47528730)
3. Havrdová E et al. (2001). Neuroimunologie. (Neuroimmunology). Prague: Maxdorf. p. 200-7, 232.
4. http://en.wikipedia.org/wiki/Drug-induced lupus erythematosus
5. https://www.zdravcentra.cz/
6. Javed A, Reder AT (2006). Therapeutic role of beta-interferons in multiple sclerosis. Pharmacol Ther. 110: 35-56. (Pubitemid 43248725)
7. Leonard C (2001). A mnemonic for SLE diagnostic criteria. Ann Rheum Dis. 60(6): 638-640.
8. Puttini PS, Atleti F, Capsoni E, Lubrano E, Doria A (2005). Drug-induced lupus erythematosus. Autoimmunity. 38(7): 507-518.
9. Robert L, Rubin L (2005). Drug-induced lupus. Toxicology. 205(2): 135-147.